Neurophysiological Biomarkers of Parkinson’s Disease

BACKGROUND: There is a need for reliable and robust Parkinson’s disease biomarkers that reflect severity and are sensitive to disease modifying investigational therapeutics. OBJECTIVE: To demonstrate the utility of EEG as a reliable, quantitative biomarker with potential as a pharmacodynamic endpoin...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Parkinsons Dis
Prif Awduron: Waninger, Shani, Berka, Chris, Stevanovic Karic, Marija, Korszen, Stephanie, Mozley, P. David, Henchcliffe, Claire, Kang, Yeona, Hesterman, Jacob, Mangoubi, Tomer, Verma, Ajay
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: IOS Press 2020
Pynciau:
Research Report
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7242849/
https://ncbi.nlm.nih.gov/pubmed/32116262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JPD-191844
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg